Status:
COMPLETED
Development of a Family-Based Treatment for Adolescent Methamphetamine Use
Lead Sponsor:
Oregon Research Institute
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Behavior and Mental Disorders
Methamphetamine Disorders
Eligibility:
All Genders
15-19 years
Phase:
PHASE1
Brief Summary
The AIMS study compares a methamphetamine-specific treatment intervention to a treatment-as-usual Functional Family Therapy (FFT) approach for adolescents ages 15 to 19. Adolescents are assigned to on...
Eligibility Criteria
Inclusion
- 15 to 19 years of age.
- Have at least one parent or parent figure willing to participate.
- Meet DSM-IV diagnostic criteria for drug-abuse or dependence, including a specific meth use disorder.
- Reports meth use on at least 5 of the previous 90 days.
- Have contact with the parent on at least 40% of the past 90 days.
- With their parent be willing to accept randomization to one of the two treatment interventions.
- Be willing to participate in the imaging task in the fMRI pilot study.
- Have basic English competency.
- Have sufficient residential stability to permit probable contact at follow-up.
Exclusion
- Evidence of psychotic or organic state of sufficient severity to interfere with understanding of study instruments and procedures.
- Have a medical or psychological condition that would preclude undergoing the fMRI scan.
- Have a sibling who is participating in the study.
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00680511
Start Date
September 1 2007
End Date
December 1 2013
Last Update
August 5 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Research Institute Center for Family and Adolescent Research
Portland, Oregon, United States, 97205